Short Interest in CellaVision AB (publ) (OTCMKTS:CLVSF) Grows By 354.6%

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totaling 6,115 shares, a growth of 354.6% from the May 31st total of 1,345 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

CellaVision AB (publ) Stock Performance

Shares of CellaVision AB (publ) stock opened at $14.00 on Friday. CellaVision AB has a twelve month low of $13.49 and a twelve month high of $17.30. The firm’s 50-day simple moving average is $13.77 and its 200-day simple moving average is $15.52.

CellaVision AB (publ) Company Profile

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.